Outcomes after intestinal re-transplant: A detailed, single-center analysis of clinical and technical factors
Intestinal Failure · 2024
DOI: 10.1016/j.intf.2024.100003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Intestinal Failure, 2024. Verfasst von Carolyn P Smullin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, David Geffen School of Medicine at UCLA, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Intestinal transplantation (ITx) has evolved into a viable option for patients suffering from intestinal failure (IF). As graft and patient survival increase, we enter a new era where re-transplantation (re-ITx) is increasingly considered. Re-ITx grafts historically are less successful than their primary counterpart. While re-ITx is challenging for the obvious reasons of a re-do operation, there are potentially modifiable pre-transplant clinical and technical factors which are not yet understood.
Methods
We conducted an in-depth review of our re-ITx experience at a high volume transplant center, and describe unique predictors associated with improved outcomes.
Results
There were 132 primary ITx performed from 1991-2021; 44 primary ITx failed (33%) and of those, 25 (56%) were re-transplanted within the time of this retrospective review. The median time to re-ITx was 13 months (5 days-6 years). I-ITx recipients were more commonly re-transplanted with liver-inclusive grafts (64%). Re-ITx recipients were more often male (p=0.05), had positive crossmatch (p=0.01), PRA>20% (p=0.03), and underwent ATG-induction (p=0.00). The mean graft survival in months in primary ITx was 74.0 (0.0 - 303.2) and in re-ITx was 60.0 (0.0 - 155.83) (p=0.37). The leading indication for re-ITx was ACR of the primary graft (64%). Successful re-ITx (graft survival >1 year) was significantly associated with ATG-induction (p=0.003). Liver-inclusive grafts demonstrated increased 1-year survival compared with liver-free grafts, but not significantly (primary ITx: 72% vs 55%; re-ITx: 75% vs 57%). Enterectomy of the primary graft prior to re-ITx appeared to increase overall graft survival after re-ITx, but not significantly (70 vs 40 months, p=0.17). Enterocolonic continuity was associated with overall longer graft survival after re-ITx (95 vs 40 months, p=0.03).
Conclusion
We demonstrate several factors to consider when evaluating patients for re-ITx, a multicenter study is needed to understand how patient selection, clinical management, and technical modifications can improve outcomes after re-ITx.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, David Geffen School of Medicine at UCLA, USA.
- Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, David Geffen School of Medicine at UCLA, USA.
- The Dumont UCLA Transplant Center, Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at UCLA, USA.
Zitieren
APA
Smullin, C. P., Venick, R. S., McDiarmid, S. V., Busuttil, R. W., & Farmer, D. G. (2024). Outcomes after intestinal re-transplant: A detailed, single-center analysis of clinical and technical factors. Intestinal Failure. https://doi.org/10.1016/j.intf.2024.100003
Vancouver
Smullin CP, Venick RS, McDiarmid SV, Busuttil RW, Farmer DG. Outcomes after intestinal re-transplant: A detailed, single-center analysis of clinical and technical factors. Intestinal Failure. 2024. doi:10.1016/j.intf.2024.100003
BibTeX
@article{Smullin2024,
author = {Smullin, Carolyn P and Venick, Robert S and McDiarmid, Suzanne V and Busuttil, Ronald W and Farmer, Douglas G},
title = {Outcomes after intestinal re-transplant: A detailed, single-center analysis of clinical and technical factors},
journal = {Intestinal Failure},
year = {2024},
doi = {10.1016/j.intf.2024.100003}
}
EUVIMED